Ivosidenib (IVO) in Patients with IDH1-Mutant Relapsed/Refractory Myelodysplastic Syndrome (R/R MDS): Updated Enrollment of a Phase 1 Dose Escalation and Expansion Study

被引：0

作者：

DiNardo, Courtney D. ^{[1
]}

Foran, James M. ^{[2
]}

Watts, Justin M. ^{[3
]}

Stein, Eytan M. ^{[4
]}

de Botton, Stephane ^{[5
]}

Fathi, Amir T. ^{[6
]}

Prince, Gabrielle T. ^{[7
]}

Stein, Anthony S. ^{[8
]}

Stone, Richard M. ^{[9
]}

Patel, Prapti A. ^{[10
]}

Roboz, Gail J. ^{[11
,12
]}

Arellano, Martha L. ^{[13
]}

Erba, Harry P. ^{[14
]}

Pigneux, Arnaud ^{[15
]}

Stuart, Robert K. ^{[16
]}

Thomas, Xavier ^{[17
]}

Uy, Geoffrey L. ^{[18
]}

Oluyadi, Abdulafeez ^{[19
]}

Lemieux, Ian R. ^{[19
]}

Liu, Hua ^{[19
]}

Wu, Bin ^{[19
]}

Winkler, Thomas ^{[19
]}

Garcia-Manero, Guillermo ^{[1
]}

Sallman, David A. ^{[20
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Mayo Clin, Jacksonville, FL 32224 USA

[3] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA

[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[5] Inst Gustave Roussy, Villejuif, France

[6] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[7] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA

[8] City Hope Med Ctr, Duarte, CA USA

[9] Dana Farber Canc Inst, Boston, MA 02115 USA

[10] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[11] Weill Cornell Med, New York, NY USA

[12] New York Presbyterian Hosp, New York, NY USA

[13] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA

[14] Univ Alabama Birmingham, Birmingham, AL USA

[15] Ctr Hosp Univ Bordeaux Haut Leveque, Pessac, France

[16] Med Univ South Carolina, Charleston, SC 29425 USA

[17] CHU Lyon Sud, Lyon, France

[18] Washington Univ, Sch Med, St Louis, MO USA

[19] Agios Pharmaceut Inc, Cambridge, MA USA

[20] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷

关键词：

clinical trial; isocitrate dehydrogenase 1; ivosidenib; myelodysplastic syndromes; targeted therapy; MDS;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MDS-265

引用

页码：S321 / S321

页数：1

共 50 条

[1] Ivosidenib (IVO) in Patients with IDH1-Mutant Relapsed/Refractory Myelodysplastic Syndrome (R/R MDS): Updated Enrollment for the MDS Sub-Study
DiNardo, Courtney D.
Foran, James M.
Watts, Justin M.
Stein, Eytan M.
de Botton, Stephane
Fathi, Amir T.
Prince, Gabrielle T.
Stein, Anthony S.
Stone, Richard M.
Patel, Prapti A.
Roboz, Gail J.
Arellano, Martha L.
Erba, Harry P.
Pigneux, Arnaud
Stuart, Robert K.
Thomas, Xavier
Uy, Geoffrey L.
Lemieux, Ian R.
Zhang, Vickie
Kapsalis, Stephanie M.
Garcia-Manero, Guillermo
Sallman, David A.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S346 - S347
[2] Ivosidenib in patients with IDH1-mutant relapsed/refractory myelodysplastic syndrome (R/R MDS): Updated enrollment and results of a phase 1 dose-escalation and expansion substudy.
Sallman, David Andrew
Foran, James M.
Watts, Justin M.
Stein, Eytan
De Botton, Stephane
Fathi, Amir Tahmasb
Prince, Gabrielle T.
Stone, Richard M.
Patel, Prapti Arvind
Roboz, Gail J.
Arellano, Martha Lucia
Erba, Harry Paul
Pigneux, Arnaud
Baratam, Praneeth
Thomas, Xavier G.
Bai, Xiaofei
Kapsalis, Stephanie M.
Garcia-Manero, Guillermo
Dinardo, Courtney Denton
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[3] Ivosidenib (AG-120) in Patients with IDH1-Mutant Relapsed/Refractory Myelodysplastic Syndrome: Updated Enrollment of a Phase 1 Dose Escalation and Expansion Study
Foran, James M.
DiNardo, Courtney D.
Watts, Justin M.
Stein, Eytan M.
De Botton, Stephane
Fathi, Amir T.
Prince, Gabrielle T.
Stein, Anthony
Stone, Richard M.
Patel, Prapti A.
Tallman, Martin S.
Choe, Sung
Wang, Hongfang
Zhang, Vickie
Fan, Bin
Yen, Katharine E.
Oluyadi, Abdulafeez
Winkler, Thomas
Hickman, Denice
Agresta, Samuel V.
Liu, Hua
Wu, Bin
Attar, Eyal C.
Kantarjian, Hagop M.
BLOOD, 2019, 134
[4] Ivosidenib (IVO; AG-120) in IDH1-Mutant Relapsed or Refractory Myelodysplastic Syndrome: Updated Results from a Phase 1 Study
DiNardo, Courtney D.
Foran, James M.
Watts, Justin M.
Stein, Eytan M.
De Botton, Stephane
Fathi, Amir T.
Prince, Gabrielle T.
Stein, Anthony S.
Stone, Richard M.
Patel, Prapti A.
Tallman, Martin S.
Choe, Sung
Wang, Hongfang
Zhang, Vickie
Dai, David
Fan, Bin
Yen, Katherine E.
Kapsalis, Stephanie K.
Hickman, Denice
Agresta, Samuel V.
Liu, Hua
Wu, Bin
Attar, Eyal C.
Kantarjian, Hagop M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S340 - S340
[5] Ivosidenib (IVO) prior to hematopoietic cell transplant for patients with IDH1-mutant relapsed or refractory acute myeloid leukemia (R/R AML).
Dinardo, Courtney Denton
Stein, Eytan
Pigneux, Arnaud
Altman, Jessica K.
Collins, Robert
Erba, Harry Paul
Watts, Justin M.
Uy, Geoffrey L.
Kapsalis, Stephanie M.
Liu, Hua
Winkler, Thomas
Roboz, Gail J.
de Botton, Stephane
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[6] Ivosidenib (AG-120) Induced Durable Remissions and Transfusion Independence in Patients with IDH1-Mutant Relapsed or Refractory Myelodysplastic Syndrome: Results from a Phase 1 Dose Escalation and Expansion Study
DiNardo, Courtney D.
Watts, Justin M.
Stein, Eytan M.
De Botton, Stephane
Fathi, Amir T.
Prince, Gabrielle T.
Stein, Anthony S.
Foran, James M.
Stone, Richard M.
Patel, Prapti A.
Tallman, Martin S.
Choe, Sung
Wang, Hongfang
Zhang, Vickie
Dai, David
Fan, Bin
Yen, Katharine E.
Kapsalis, Stephanie M.
Hickman, Denice
Agresta, Samuel V.
Liu, Hua
Wu, Bin
Attar, Eyal C.
Kantarjian, Hagop M.
BLOOD, 2018, 132
[7] Ivosidenib in Mutant IDH1 Relapsed/ Refractory Myelodysplastic Syndrome: Updated Substudy Results
DiNardo, Courtney D.
Roboz, Gail J.
Watts, Justin M.
Madanat, Yazan F.
Prince, Gabrielle T.
Baratam, Praneeth
de Botton, Stephane
Stein, Anthony
Foran, James M.
Arellano, Martha L.
Sallman, David A.
Marchione, Dylan M.
Bai, Xiaofei
Patel, Prapti A.
Kapsalis, Stephanie M.
Garcia-Manero, Guillermo
Fathi, Amir T.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S366 - S367
[8] Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome
DiNardo, Courtney D.
Roboz, Gail J.
Watts, Justin M.
Madanat, Yazan F.
Prince, Gabrielle T.
Baratam, Praneeth
de Botton, Stphane
Stein, Anthony
Foran, James M.
Arellano, Martha L.
Sallman, David A.
Hossain, Mohammad
Marchione, Dylan M.
Bai, Xiaofei
Patel, Prapti A.
Kapsalis, Stephanie M.
Garcia-Manero, Guillermo
Fathi, Amir T.
BLOOD ADVANCES, 2024, 8 (15) : 4209 - 4220
[9] Ivosidenib (IVO; AG-120) in mutant IDH1 relapsed/refractory acute myeloid leukemia (R/R AML): Results of a phase 1 study.
Pollyea, Daniel Aaron
Dinardo, Courtney Denton
de Botton, Stephane
Stein, Eytan
Roboz, Gail J.
Mims, Alice S.
Swords, Ronan T.
Altman, Jessica K.
Collins, Robert
Mannis, Gabriel N.
Uy, Geoffrey L.
Donnellan, William Bruce
Pigneux, Arnaud
Fathi, Amir Tahmasb
Liu, Hua
Wu, Bin
Attar, Eyal C.
Tallman, Martin S.
Stone, Richard M.
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[10] Ivosidenib (IVO) Prior to Hematopoietic Cell Transplant (HCT) for Patients with IDH1-Mutant Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) Who Cannot Tolerate Intensive Chemotherapy (IC)
DiNardo, Courtney D.
Stein, Eytan M.
Pigneux, Arnaud
Altman, Jessica K.
Collins, Robert
Erba, Harry P.
Watts, Justin M.
Uy, Geoffrey L.
Wu, Bin
Choe, Sung
Kapsalis, Stephanie M.
Liu, Hua
Winkler, Thomas
Roboz, Gail J.
de Botton, Stephane
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S197 - S198

← 1 2 3 4 5 →